Butrans skin patches contain buprenorphine, associate opioid pain medication. Associate opioid is usually referred to as a narcotic.
The Butrans transdermal patch is for nonstop treatment of moderate to severe chronic pain that’s not controlled bydifferent medicines. This medication isn’t to be used on associate as-needed basis for pain.
Butrans may additionally be used for functions unlisted during this medication guide.
Submit your review
Get emergency medical help if you have signs of an allergic reaction to Butrans: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using Butrans and call your doctor at once if you have:
weak or shallow breathing, deep sighs, snoring that is new or unusual;
chest pain, fast heart rate, seizure (convulsions);
a light-headed feeling, like you might pass out;
blisters, swelling, or severe irritation where the patch was worn; or
liver problems - nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Buprenorphine is more likely to cause breathing problems in older adults and people who are severely ill, malnourished, or otherwise debilitated.
Common Butrans side effects may include:
constipation, nausea, vomiting, dry mouth, stomach pain;
headache, dizziness, drowsiness, tired feeling; or
redness, itching, or mild skin rash where the patch was worn.
BUTRANS should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain. BUTRANS doses of 7.5, 10, 15, and 20 mcg/hour are for opioid-experienced patients only. Initiate the dosing regimen for each patient individually; take into account the patient's prior analgesic treatment experience and risk factors for addiction, abuse, and misuse. Monitor patients closely for respiratory depression, especially within the first 24-72 hours of initiating therapy with BUTRANS.